Form 8-K - Current report:
SEC Accession No. 0001683168-19-002001
Filing Date
2019-06-25
Accepted
2019-06-25 09:04:10
Documents
3
Period of Report
2019-06-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K xenetic_8k.htm 8-K 21525
2 FORM OF WARRANT xenetic_ex0401.htm EX-4.1 117052
3 CONSENT AGREEMENT xenetic_ex1001.htm EX-10.1 67243
  Complete submission text file 0001683168-19-002001.txt   207188
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

EIN.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37937 | Film No.: 19917126
SIC: 2834 Pharmaceutical Preparations